These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 22093144

  • 1. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK, Oh JJ, Byun SS, Hwang SI, Choo MS, Lee SE.
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
    Chiang IN, Chang SJ, Pu YS, Huang KH, Yu HJ, Huang CY.
    Urol Int; 2009 Jul; 82(3):270-5. PubMed ID: 19440012
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P.
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [Abstract] [Full Text] [Related]

  • 7. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
    Ochiai A, Fritsche HA, Babaian RJ.
    Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145
    [Abstract] [Full Text] [Related]

  • 8. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [Abstract] [Full Text] [Related]

  • 9. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
    Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K.
    Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
    [Abstract] [Full Text] [Related]

  • 10. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
    Mabjeesh NJ, Lidawi G, Chen J, German L, Matzkin H.
    BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
    [Abstract] [Full Text] [Related]

  • 11. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.
    Urol Int; 2009 Oct; 82(3):280-5. PubMed ID: 19440014
    [Abstract] [Full Text] [Related]

  • 12. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Oct; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 13. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, Saito I.
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [Abstract] [Full Text] [Related]

  • 14. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM.
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [Abstract] [Full Text] [Related]

  • 17. Is there a role for serum human tissue kallikrein in detection of prostate cancer?
    Ochiai A, Shukla A, Davis JW, Fritsche HA, Bhadkamkar V, Babaian RJ.
    Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108
    [Abstract] [Full Text] [Related]

  • 18. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels.
    Tanaka N, Fujimoto K, Chihara Y, Torimoto M, Hirao Y, Konishi N, Saito I.
    Prostate Cancer Prostatic Dis; 2007 Sep; 10(3):274-8. PubMed ID: 17339878
    [Abstract] [Full Text] [Related]

  • 19. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [Abstract] [Full Text] [Related]

  • 20. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
    Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.
    N Engl J Med; 2003 Jul 24; 349(4):335-42. PubMed ID: 12878740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.